Index by author

March 2024; Volume 44,Issue 3

Special Issue of Anticancer Research on NEW ANTICANCER AGENTS 2024

  1. Adachi, HIDEKI

    1. Comparison of Oncological Outcomes of Pembrolizumab as Second-line Therapy and Maintenance Avelumab Therapy in Advanced Urothelial Carcinoma After Platinum-based Chemotherapy
      TETSUYA SHINDO, KOHEI HASHIMOTO, ATSUSHI TAKAHASHI, SHINTARO MIYAMOTO, YASUHARU KUNISHIMA, SHUNSUKE SATO, FUMIMASA FUKUTA, YOSHIKI HIYAMA, AKIO TAKAYANAGI, RYUICHI KATO, ATSUSHI WANIFUCHI, YOHEI UEKI, MANABU OKADA, HIDEKI ADACHI, KO KOBAYASHI, TOSHIAKI TANAKA and NAOYA MASUMORI; on behalf of the Sapporo Medical University Urologic Oncology Consortium
      Anticancer Research March 2024, 44 (3) 1271-1279; DOI: https://doi.org/10.21873/anticanres.16922

  2. Adachi, RYOHEI

    1. Open Access
      The Effect of Photodynamic Therapy Using 5-Aminolevulinic Acid in Bone and Soft Tissue Sarcoma Cells
      RYOHEI ADACHI, TOMOKI NAKAMURA, KENTA NAKATA, TERUYA UCHIYAMA, TOMOHITO HAGI, KUNIHIRO ASANUMA and AKIHIRO SUDO
      Anticancer Research March 2024, 44 (3) 963-969; DOI: https://doi.org/10.21873/anticanres.16891

  3. Amagase, KIKUKO

    1. Orally Administrated Glutamate Restored EAAT1 and 3 Expression Levels Suppressed in 5-Fluorouracil-damaged Intestinal Epithelial Cells
      SHIZUKA JONAN, MAI HANEDA and KIKUKO AMAGASE
      Anticancer Research March 2024, 44 (3) 1143-1147; DOI: https://doi.org/10.21873/anticanres.16909

  4. Ando, MASASHI

    1. Safety and Efficacy of Gemcitabine Plus Cisplatin Against Recurrent/Metastatic Nasopharyngeal Carcinoma: A Retrospective Study
      HIROYUKI KODAMA, SHIGENORI KADOWAKI, TAIKO NAKAZAWA, YUKI MATSUBARA, YUKIYA NARITA, KAZUNORI HONDA, TOSHIKI MASUISHI, HIROYA TANIGUCHI, MASASHI ANDO, YUTARO KOIDE, HIROYUKI TACHIBANA, TAKESHI KODAIRA, MICHI SAWABE, HOSHINO TERADA, SHINTARO BEPPU, DAISUKE NISHIKAWA, HIDENORI SUZUKI, NOBUHIRO HANAI and KEI MURO
      Anticancer Research March 2024, 44 (3) 1227-1232; DOI: https://doi.org/10.21873/anticanres.16918

  5. Ando, YUICHI

    1. Open Access
      Efficacy and Safety of Anti-angiogenic Agents for Cancer Patients With Proteinuria or a History of Proteinuria: A Systematic Review
      TAIGO KATO, SHIMON KURASAWA, KENTARO TAKEZAWA, YUTAKA FUJIWARA, YOSHINARI YASUDA and YUICHI ANDO
      Anticancer Research March 2024, 44 (3) 889-894; DOI: https://doi.org/10.21873/anticanres.16882

  6. Andonegui-elguera, MARCO A.

    1. Antiproliferative and Antimigratory Activity of Poly-gallic Acid in Cancer Cell Lines
      CARMEN G. HERNANDEZ-VALENCIA, GRISELDA RODRIGUEZ-MARTINEZ, ANDRES M. CARRILES-PEREZ, DANIEL GONZALEZ-PEREZ, CARMINA ORTEGA-SANCHEZ, MARCO A. ANDONEGUI-ELGUERA, YESSICA ZAMUDIO-CUEVAS, JAVIER FERNANDEZ-TORRES, MIGUEL A. HERNANDEZ-VALDEPENA, MIQUEL GIMENO and ROBERTO SANCHEZ-SANCHEZ
      Anticancer Research March 2024, 44 (3) 1201-1208; DOI: https://doi.org/10.21873/anticanres.16915

  7. Ardjmand, DANIEL

    1. Open Access
      Selective Synergy of Rapamycin Combined With Methioninase on Cancer Cells Compared to Normal Cells
      DANIEL ARDJMAND, YUTARO KUBOTA, MOTOKAZU SATO, QINGHONG HAN, KOHEI MIZUTA, SEI MORINAGA and ROBERT M. HOFFMAN
      Anticancer Research March 2024, 44 (3) 929-933; DOI: https://doi.org/10.21873/anticanres.16887

  8. Asanuma, KUNIHIRO

    1. Screening for Synergistic Reagents With Pazopanib Against Osteosarcoma Using a Compound Library
      YUKI YADA, KUNIHIRO ASANUMA, TAKUYA KAKIMTO, KAZUMA OKUNO, TAKAYUKI OKAMOTO, TAKAHIRO IINO, TOMOKI NAKAMURA and AKIHIRO SUDO
      Anticancer Research March 2024, 44 (3) 1071-1078; DOI: https://doi.org/10.21873/anticanres.16902
    2. Open Access
      The Effect of Photodynamic Therapy Using 5-Aminolevulinic Acid in Bone and Soft Tissue Sarcoma Cells
      RYOHEI ADACHI, TOMOKI NAKAMURA, KENTA NAKATA, TERUYA UCHIYAMA, TOMOHITO HAGI, KUNIHIRO ASANUMA and AKIHIRO SUDO
      Anticancer Research March 2024, 44 (3) 963-969; DOI: https://doi.org/10.21873/anticanres.16891

  9. Baldini, NICOLA

    1. Repurposing of Loperamide as a New Drug With Anticancer Activity for Human Osteosarcoma
      LAURA RONCUZZI, FRANCESCA PERUT and NICOLA BALDINI
      Anticancer Research March 2024, 44 (3) 1063-1070; DOI: https://doi.org/10.21873/anticanres.16901

  10. Baudrexl, JOSEFINE

    1. Open Access
      Evaluation of Five-year Overall Survival Rates Among 18,331 Head and Neck Cancer Patients Exposed to Different Targeted Therapies Through Real-world Data in a Case-controlled Study
      JOSEFINE BAUDREXL, ANDREAS SAKKAS, SEBASTIAN PIETZKA, SPYRIDOULA DERKA, GEORGIA VAIRAKTARI, MARIO SCHEURER, ALEXANDER SCHRAMM, FRANK WILDE and MARCEL EBELING
      Anticancer Research March 2024, 44 (3) 1247-1270; DOI: https://doi.org/10.21873/anticanres.16921
« Previous (Pages : 1 2 3 4 5 6 ... 35) Next »
Back to top

In this issue